January 6, 2011 -- United Laboratories International Holdings has received SFDA approval for three additional insulin products, bringing its total in this sector to five. The company will price its insulin products at a 10-15% discount to similar drugs already on the market. United Labs said it plans to invest up to 500 million RMB ($75.5 million) in its insulin business over the next few years. More details....
